Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

15.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generating Monoclonal Antibodies.

Cold Spring Harbor protocols·2022
Same author

Determining the Class and Subclass of Monoclonal Antibodies Using Antibody Capture on Anti-Immunoglobulin Antibody-Coated Plates.

Cold Spring Harbor protocols·2022
Same author

Immunizing Animals.

Cold Spring Harbor protocols·2022
Same author

Hybridoma Screening by Antibody Capture: Flow Cytometry/FACS with Permeabilized Cells to Detect Intracellular Binding.

Cold Spring Harbor protocols·2022
Same author

Hybridoma Screening by Antibody Capture: Flow Cytometry/FACS with Whole Cells to Detect Cell-Surface Binding.

Cold Spring Harbor protocols·2022
Same author

Hybridoma Screening by Antibody Capture: Enzyme-Linked Detection (Indirect ELISA) in Polyvinyl Chloride Wells.

Cold Spring Harbor protocols·2022

Related Experiment Video

Updated: Oct 18, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

42.5K

Growing Hybridomas.

Edward A Greenfield

    Cold Spring Harbor Protocols
    |October 2, 2021
    PubMed
    Summary
    This summary is machine-generated.

    This study details methods for growing myeloma and hybridoma cell lines, producing monoclonal antibodies, and employing drug selection techniques for hybridoma research.

    More Related Videos

    Generation of Monoclonal Antibodies Against Natural Products
    12:15

    Generation of Monoclonal Antibodies Against Natural Products

    Published on: April 6, 2019

    11.2K
    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    18.7K

    Related Experiment Videos

    Last Updated: Oct 18, 2025

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    42.5K
    Generation of Monoclonal Antibodies Against Natural Products
    12:15

    Generation of Monoclonal Antibodies Against Natural Products

    Published on: April 6, 2019

    11.2K
    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    18.7K

    Area of Science:

    • Biotechnology
    • Immunology
    • Cell Biology

    Background:

    • Hybridoma technology is crucial for producing monoclonal antibodies.
    • Myeloma and hybridoma cell line maintenance requires specific protocols.
    • Monoclonal antibody production is a key application in biomedical research.

    Purpose of the Study:

    • To provide an overview of essential techniques for hybridoma and myeloma cell culture.
    • To describe the processes involved in monoclonal antibody production and collection.
    • To outline drug selection strategies commonly used in hybridoma applications.

    Main Methods:

    • Cell culture techniques for myeloma and hybridoma lines.
    • Methods for antibody purification and collection.
    • Drug selection protocols for hybridoma screening.

    Main Results:

    • Established protocols for successful cell line maintenance.
    • Efficient methods for monoclonal antibody harvesting.
    • Effective drug selection strategies identified.

    Conclusions:

    • Standardized techniques ensure reliable monoclonal antibody production.
    • Optimized cell culture and selection methods are vital for research success.
    • This work provides a foundational guide for hybridoma applications.